US 10226472
Methods for the treatment of breast cancer
granted A61KA61K31/4196A61K31/4406
Quick answer
US patent 10226472 (Methods for the treatment of breast cancer) held by Syndax Pharmaceuticals, Inc. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syndax Pharmaceuticals, Inc.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4196, A61K31/4406, A61K31/566, A61K31/5685